S&P 500

6.092,09

-0,44%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
Pressure Biosciences Inc (CE) (PBIO)
Pressure Biosciences Inc (CE) (PBIO) Notícias

PBIO

Pressure Biosciences (CE) (PBIO)

Pressure Biosciences Inc (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:PBIO

1 2 3 4 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
30/09/2024	17:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:PBIO	Pressure Biosciences Inc (CE)
06/09/2024	18:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:PBIO	Pressure Biosciences Inc (CE)
19/08/2024	18:20	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:PBIO	Pressure Biosciences Inc (CE)
17/07/2024	13:32	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:PBIO	Pressure Biosciences Inc (CE)
07/06/2024	18:28	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:PBIO	Pressure Biosciences Inc (CE)
27/02/2024	15:42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:PBIO	Pressure Biosciences Inc (CE)
05/05/2023	17:43	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:PBIO	Pressure Biosciences Inc (CE)
03/04/2023	14:06	Edgar (US Regulatory)	Notification That Annual Report Will Be Submitted Late (nt 10-k)	USOTC:PBIO	Pressure Biosciences Inc (CE)
28/03/2023	18:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:PBIO	Pressure Biosciences Inc (CE)
06/12/2022	19:30	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:PBIO	Pressure Biosciences Inc (CE)
15/11/2022	19:23	Edgar (US Regulatory)	Notification That Quarterly Report Will Be Submitted Late (nt 10-q)	USOTC:PBIO	Pressure Biosciences Inc (CE)
15/08/2022	19:08	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:PBIO	Pressure Biosciences Inc (CE)
12/08/2021	09:34	InvestorsHub NewsWire	Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations	USOTC:PBIO	Pressure Biosciences Inc (CE)
05/08/2021	09:13	InvestorsHub NewsWire	Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability	USOTC:PBIO	Pressure Biosciences Inc (CE)
30/07/2021	15:54	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:PBIO	Pressure Biosciences Inc (CE)
21/07/2021	10:46	InvestorsHub NewsWire	Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue	USOTC:PBIO	Pressure Biosciences Inc (CE)
16/07/2021	15:44	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:PBIO	Pressure Biosciences Inc (CE)
01/07/2021	09:14	InvestorsHub NewsWire	Pressure BioSciences Novel UST™ Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most ..cont	USOTC:PBIO	Pressure Biosciences Inc (CE)
15/04/2021	18:31	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:PBIO	Pressure Biosciences Inc (CE)
20/01/2021	11:18	InvestorsHub NewsWire	Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via	USOTC:PBIO	Pressure Biosciences Inc (CE)
17/12/2020	11:00	InvestorsHub NewsWire	Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams	USOTC:PBIO	Pressure Biosciences Inc (CE)
15/12/2020	12:19	InvestorsHub NewsWire	Pressure BioSciences to Present at Upcoming Life Sciences Investor Forum	USOTC:PBIO	Pressure Biosciences Inc (CE)
17/11/2020	13:12	InvestorsHub NewsWire	Pressure BioSciences, Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update	USOTC:PBIO	Pressure Biosciences Inc (CE)
16/11/2020	17:20	InvestorsHub NewsWire	Pressure BioSciences, Inc. to Discuss Third Quarter 2020 Financial Results and Provide Business Update	USOTC:PBIO	Pressure Biosciences Inc (CE)
11/11/2020	12:38	InvestorsHub NewsWire	Pressure BioSciences Awarded First U.S. Patent for Revolutionary Ultra Shear Technology Platform	USOTC:PBIO	Pressure Biosciences Inc (CE)
11/06/2020	10:00	InvestorsHub NewsWire	$3,500,000 Initial Order for FDA-Registered, Premium Hand Sanitizer Catapults SkinScience Labs, a Pending Accretive Acquisition	USOTC:PBIO	Pressure Biosciences Inc (CE)
28/05/2020	10:39	InvestorsHub NewsWire	Pressure BioSciences Announces Launch of Novel, FDA Registered Immune Booster by Pending Merger Partner Cannaworx, Inc.	USOTC:PBIO	Pressure Biosciences Inc (CE)
14/05/2020	09:45	InvestorsHub NewsWire	Pressure BioSciences Announces Launch of FDA-Registered Hand Sanitizer as First Product Developed Through Pending Merger Part...	USOTC:PBIO	Pressure Biosciences Inc (CE)
07/05/2020	09:45	InvestorsHub NewsWire	Former L'Oréal President Jim Morrison Appointed as CEO To Lead Availa Bio Upon Merger of Pressure BioSciences	USOTC:PBIO	Pressure Biosciences Inc (CE)
05/05/2020	10:39	InvestorsHub NewsWire	Pressure BioSciences Announces Planned Name Change to "Availa Bio" Following Completion of Cannaworx and SkinScience Labs	USOTC:PBIO	Pressure Biosciences Inc (CE)